1. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients. (2nd September 2021) Authors: Chanchlani, Neil; Lin, Simeng; Chee, Desmond; Hamilton, Benjamin; Nice, Rachel; Arkir, Zehra; Bewshea, Claire; Cipriano, Bessie; Derikx, Lauranne A A P; Dunlop, Allan; Greathead, Louise; Griffiths, Rachel L; Ibraheim, Hajir; Kelleher, Peter; Kok, Klaartje B; Lees, Charlie W; MacDonald, Jonathan; ... Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 3(2022) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗